BloodScan Biotech Inc.

BloodScan Biotech Inc. is dedicated to revolutionizing cancer care through innovative liquid biopsy technology. As a biotechnology company focused on the application of advanced research, BloodScan Biotech Inc. is committed to setting a new global standard in the field.

BloodScan Biotech Inc.'s core technology, the Labyrinth One—Automated CTC Enrichment System, showcases innovative designs that significantly enhance the purity, efficiency, and viability of circulating tumor cell (CTC) extraction from blood samples. This groundbreaking advancement promises to have a profound impact on cancer diagnosis, monitoring, and personalized medicine, with the potential to achieve breakthrough progress in cancer care.

BloodScan Biotech Inc. integrates industry, academia, and research to drive improvements throughout the entire cancer diagnosis and treatment cycle, leveraging cutting-edge biotechnology. We invite the management team at BloodScan Biotech Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.